These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 33364113)

  • 1. Bexarotene: A Rare Cause of Misleading Thyroid Function Tests.
    Pattan V; Schaab K; Sundaresh V
    Cureus; 2020 Nov; 12(11):e11591. PubMed ID: 33364113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bexarotene-induced central hypothyroidism assessed by TRH stimulation test in cutaneous T-cell lymphoma patients.
    Toi N; Kurajoh M; Miyaoka D; Nagata Y; Yamada S; Imanishi Y; Hayashi D; Tateishi C; Inaba M; Tsuruta D; Morita A; Emoto M
    Endocr J; 2022 Jan; 69(1):101-105. PubMed ID: 34433736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bexarotene-induced hypothyroidism: Characteristics and therapeutic strategies.
    Makita N; Manaka K; Sato J; Mitani K; Nangaku M; Iiri T
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):195-200. PubMed ID: 30903705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EVALUATION OF TREATMENT OF CENTRAL HYPOTHYROIDISM VERSUS PRIMARY HYPOTHYROIDISM IN RELATION TO LEVOTHYROXINE REPLACEMENT DOSE.
    Zeni D; Rissetti G; Ongaratti B; Pereira-Lima JF; Rech CGSL; Oliveira MDC
    Endocr Pract; 2019 Jul; 25(7):663-668. PubMed ID: 30865544
    [No Abstract]   [Full Text] [Related]  

  • 5. ITALIAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS STATEMENT-REPLACEMENT THERAPY FOR PRIMARY HYPOTHYROIDISM: A BRIEF GUIDE FOR CLINICAL PRACTICE.
    Guglielmi R; Frasoldati A; Zini M; Grimaldi F; Gharib H; Garber JR; Papini E
    Endocr Pract; 2016 Nov; 22(11):1319-1326. PubMed ID: 27482609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triiodothyronine levels in athyreotic individuals during levothyroxine therapy.
    Jonklaas J; Davidson B; Bhagat S; Soldin SJ
    JAMA; 2008 Feb; 299(7):769-77. PubMed ID: 18285588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bexarotene-induced hypothyroidism: bexarotene stimulates the peripheral metabolism of thyroid hormones.
    Smit JW; Stokkel MP; Pereira AM; Romijn JA; Visser TJ
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2496-9. PubMed ID: 17440015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Out-of-Reference Range Thyroid-Stimulating Hormone Levels in Levothyroxine-Treated Primary Hypothyroid Patients: A Multicenter Observational Study.
    Yavuz DG; Yazıcı D; Keskin L; Atmaca A; Sancak S; Saraç F; Şahin İ; Dikbaş O; Hekimsoy Z; Yalın S; Uygur M; Yılmaz M; Yirmibeşcik S; Asmaz Ö
    Front Endocrinol (Lausanne); 2017; 8():215. PubMed ID: 28955301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Thyroid Hormone Balance in Levothyroxine Monotherapy-Treated Patients with Atrophic Thyroid After Radioiodine Treatment for Graves' Disease.
    Ito M; Kawasaki M; Danno H; Kohsaka K; Nakamura T; Hisakado M; Yoshioka W; Kasahara T; Kudo T; Nishihara E; Fukata S; Nishikawa M; Nakamura H; Miyauchi A
    Thyroid; 2019 Oct; 29(10):1364-1370. PubMed ID: 31411123
    [No Abstract]   [Full Text] [Related]  

  • 10. Marked lowering of high-density lipoprotein cholesterol levels due to high dose bexarotene therapy.
    Basani S; Garg A
    J Clin Lipidol; 2015; 9(6):832-836. PubMed ID: 26687705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No Effect of the Thr92Ala Polymorphism of Deiodinase-2 on Thyroid Hormone Parameters, Health-Related Quality of Life, and Cognitive Functioning in a Large Population-Based Cohort Study.
    Wouters HJ; van Loon HC; van der Klauw MM; Elderson MF; Slagter SN; Kobold AM; Kema IP; Links TP; van Vliet-Ostaptchouk JV; Wolffenbuttel BH
    Thyroid; 2017 Feb; 27(2):147-155. PubMed ID: 27786042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Optimal Combination LT4 + LT3 Therapy for Hypothyroidism Based on Residual Thyroid Function.
    DiStefano J; Jonklaas J
    Front Endocrinol (Lausanne); 2019; 10():746. PubMed ID: 31803137
    [No Abstract]   [Full Text] [Related]  

  • 13. Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options.
    Hoermann R; Midgley JEM; Larisch R; Dietrich JW
    Drugs Context; 2019; 8():212597. PubMed ID: 31516533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of levothyroxine supplementation in extremely low birth weight infants who have transient hypothyroidism without thyroid-stimulating hormone elevation.
    Nomura S; Ikegami H; Wada H; Tamai H; Funato M; Shintaku H
    Osaka City Med J; 2014 Jun; 60(1):29-37. PubMed ID: 25272565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switch from tablet levothyroxine to oral solution resolved reduced absorption by intestinal parasitosis.
    Tortora A; La Sala D; Vitale M
    Endocrinol Diabetes Metab Case Rep; 2019 Mar; 2019():. PubMed ID: 30897550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of proton pump inhibitors on serum thyroid-stimulating hormone level in euthyroid patients treated with levothyroxine for hypothyroidism.
    Sachmechi I; Reich DM; Aninyei M; Wibowo F; Gupta G; Kim PJ
    Endocr Pract; 2007; 13(4):345-9. PubMed ID: 17669709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMPACT OF RAMADAN FASTING ON THYROID STATUS AND QUALITY OF LIFE IN PATIENTS WITH PRIMARY HYPOTHYROIDISM: A PROSPECTIVE COHORT STUDY FROM KARACHI, PAKISTAN.
    Sheikh A; Mawani M; Mahar SA
    Endocr Pract; 2018 Oct; 24(10):882-888. PubMed ID: 29975574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology, diagnosis, and treatment recommendations for central hypothyroidism associated with bexarotene therapy for cutaneous T-cell lymphoma.
    Sherman SI
    Clin Lymphoma; 2003 Mar; 3(4):249-52. PubMed ID: 12672276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvements in Quality of Life and Thyroid Parameters in Hypothyroid Patients on Ethanol-Free Formula of Liquid Levothyroxine Therapy in Comparison to Tablet LT4 Form: An Observational Study.
    Bornikowska K; Gietka-Czernel M; Raczkiewicz D; Glinicki P; Zgliczyński W
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe TSH Elevation and Pituitary Enlargement After Changing Thyroid Replacement to Compounded T4/T3 Therapy.
    Pappy AL; Oyesiku N; Ioachimescu A
    J Investig Med High Impact Case Rep; 2016; 4(3):2324709616661834. PubMed ID: 27540557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.